Biopharmaceutical Industry Contributions to State and U.S. Economies

Biopharmaceutical Industry Contributions to State and U.S. Economies > State Summary > Massachusetts Massachusetts
State Summary

Multiplier Impacts

Concept (2003 Figures) Multiplier	Multiplier	Total Impact	Direct Impact	Indirect Impact	Induced Impact
Employment (Thous.)	3.6	77.3	21.4	28.7	27.2
Earnings (US$ Mil.)	2.6	3,961.8	1,541.8	1,347.3	1,072.7
Real Output (US$ 96, Mil.)	2.1	4,822.6	2,351.6	1,225.6	1,245.4
Tax Total (US$ Mil.)	-	1,459.4	-	-	-
Federal (US$ Mil.)	-	1,186.0	-	-	-
State & Local (US$ Mil.)	-	273.4	-	-	-

Sources: Milken Institute, Economy.com, BLS, BEA, Tax Foundation.

Biopharmaceutical Employment — Multiplier Impacts, 2003

Direct-Effect Employment Multiplier	Total Impact (Thous.)	Direct Impact (Thous.)	Indirect + Induced (Thous.)	Induced Impact (Thous.)	Indirect Impact (Thous.)	Induced Share	Indirect Share
3.61	77.28	21.42	55.86	27.16	28.70	0.49	0.51

Biopharmaceutical Real Output — Multiplier Impacts, 2003

Final-Demand Output Multiplier	Total Impact (US$ 96, Mil.)	Direct Impact (US$ 96, Mil.)	Indirect + Induced (US$ 96, Mil.)	Induced Impact (US$ 96, Mil.)	Indirect Impact (US$ 96, Mil.)	Induced Share	Indirect Share
2.05	4,822.64	2,351.62	2,471.03	1,245.41	1,225.61	0.50	0.50

Biopharmaceutical Earnings — Multiplier Impacts, 2003

Direct-Effect Earnings Multiplier	Total Impact (US$ Mil.)	Direct Impact (US$ Mil.)	Indirect + Induced (US$ Mil.)	Induced Impact (US$ Mil.)	Indirect Impact (US$ Mil.)	Induced Share	Indirect Share
2.57	3,961.78	1,541.78	2,420.00	1,072.67	1,347.33	0.44	0.56

Taxes

(Biopharmaceuticals, 2003)	State & Local Taxes (US$ Mil.)	Federal Taxes (US$ Mil.)	Total Taxes (US$ Mil.)
Total Tax Receipts*	273.4	1,186.0	1,459.4
Personal Income Tax Receipts	205.5	1,055.2	1,260.8
Sales Tax Receipts	20.8	-	20.8
Corporate Income Tax Receipts	47.1	130.8	177.9

Sources: Milken Institute, BEA, Tax Foundation.
* Includes Personal Income Tax, Sales Tax, and Corporate Income Tax Receipts

Industry Data

Total Biopharmaceutical (NAICS 3254 + NAICS 5417102) Overview

Employment Size (Thous.)			Employment Growth			Employment LQ (US=1)	Real Output Level (US$ '96, Mill.)			Real Output Growth			Real Output LQ (US=1)	Real Output Per Employee (US$ '96, Thous.)	Wage Per Employee (US$, Thous.)
1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	2003	2003
5.225	10.890	21.419	108.4%	96.7%	310.0%	2.15	308.1	839.5	2,351.6	172.5%	180.1%	663.3%	1.32	109.8	72.0

Employment Level (1983-2003) — Total Biopharmcaeutical, In Thousands

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
5.2	7.2	7.1	7.4	8.3	9.2	8.8	8.8	9.0	9.7	10.9	12.0	12.7	13.8	15.1	16.1	17.1	17.8	19.6	20.9	21.4

Real Output Level (1983-2003) — Total Biopharmcaeutical, In US$ '96 Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
308.1	437.2	445.7	493.9	567.2	618.0	641.3	660.8	654.1	710.9	839.5	1,022.8	1,002.5	1,174.5	1,345.3	1,455.7	1,760.8	2,013.5	2,070.6	2,185.8	2,351.6

Real Output Per Employee Level (1983-2003) — Total Biopharmaceutical, In US$ '96 Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
59.0	60.9	63.0	66.7	68.6	67.5	73.2	74.7	73.0	73.0	77.1	85.4	78.8	85.1	89.1	90.3	102.8	112.9	105.8	104.6	109.8

Wages Per Employee Level (1983-2003) — Total Biopharmaceutical, In US$ Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
24.1	26.0	28.0	29.7	31.5	32.9	36.8	38.9	38.8	42.2	43.4	44.6	48.1	51.8	55.8	58.2	63.4	71.6	70.4	68.0	72.0

Pharmaceutical and Medicine Manufacturing (NAICS 3254) Overview

Employment Size (Thous.)			Employment Growth			Employment LQ (US=1)	Real Output Level (US$ '96, Mill.)			Real Output Growth			Real Output LQ (US=1)	Real Output Per Employee (US$ '96, Thous.)	Wage Per Employee (US$, Thous.)
1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	2003	2003
2.004	3.505	8.524	74.9%	143.2%	325.3%	1.23	124.6	331.2	1,499.2	165.7%	352.7%	1102.9%	0.97	175.9	104.8

Employment Level (1983-2003) — Pharmaceutical and Medicine Manufacturing, In Thousands

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
2.004	2.149	2.201	2.171	2.497	2.674	2.248	2.248	2.450	2.852	3.505	4.200	4.702	5.229	5.790	6.124	6.562	6.704	7.108	7.775	8.524

Real Output Level (1983-2003) — Pharmaceutical and Medicine Manufacturing, In US$ '96 Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
124.6	150.5	157.5	170.1	195.8	206.5	189.2	197.8	204.1	258.6	331.2	522.4	465.8	565.7	687.6	742.2	1,003.0	1,131.8	1,160.2	1,348.2	1,499.2

Real Output Per Employee Level (1983-2003) — Pharmaceutical and Medicine Manufacturing, In US$ Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
62.2	70.0	71.6	78.3	78.4	77.2	84.2	88.0	83.3	90.7	94.5	124.4	99.1	108.2	118.8	121.2	152.9	168.8	163.2	173.4	175.9

Wages Per Employee Level (1983-2003) — Pharmaceutical and Medicine Manufacturing, In US$ Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
24.5	28.0	30.4	31.5	32.3	33.7	40.4	41.8	39.4	45.2	46.9	55.1	58.6	62.2	68.6	74.0	84.6	96.1	101.9	102.9	104.8

R&D in the Life Sciences (NAICS5417102) Overview

Employment Size (Thous.)			Employment Growth			Employment LQ (US=1)	Real Output Level (US$ '96, Mill.)			Real Output Growth			Real Output LQ (US=1)	Real Output Per Employee (US$ '96, Thous.)	Wage Per Employee (US$, Thous.)
1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	1983	1993	2003	'83-'93	'93-'03	'83-'03	2003	2003	2003
3.221	7.385	12.895	129.3%	74.6%	300.4%	2.88	183.5	508.3	852.4	177.1%	67.7%	364.6%	3.65	66.1	50.3

Employment Level (1983-2003) — R&D in the Life Sciences, In Thousands

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
3.221	5.030	4.874	5.239	5.773	6.486	6.518	6.596	6.507	6.881	7.385	7.782	8.016	8.575	9.311	10.005	10.559	11.132	12.463	13.117	12.895

Real Output Level (1983-2003) — R&D in the Life Sciences, In US$ '96 Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
183.5	286.8	288.2	323.8	371.4	411.5	452.0	463.0	450.0	452.3	508.3	500.4	536.7	608.8	657.7	713.6	757.7	881.7	910.4	837.6	852.4

Real Output Per Employee Level (1983-2003) — R&D in the Life Sciences, In US$ Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
57.0	57.0	59.1	61.8	64.3	63.4	69.4	70.2	69.2	65.7	68.8	64.3	67.0	71.0	70.6	71.3	71.8	79.2	73.1	63.9	66.1

Wages Per Employee Level (1983-2003) — R&D in the Life Sciences, In US$ Millions

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
23.9	25.2	27.0	29.0	31.1	32.5	35.6	37.9	38.5	41.0	41.7	38.9	42.0	45.5	47.8	48.4	50.2	56.8	52.4	47.3	50.3

Biopharmaceutical and Life Science Overview by Census Region

Innovation Pipeline

Biopharamceutical Research Funding Rank Statistic Score

Industrial R&D to Biopharmaceutical (Dollars per Capita, 2002)
3 176.87 87.42

National Institutes of Health Funding (Total Dollars per Capita, 2003)
1 343.21 100.00

NIH Funding to Biopharmaceuticals (Dollars per Capita, 2003)
2 76.13 98.04

Academic R&D to Biopharmaceuticals (Dollars per Capita, 2002)
3 116.59 95.83

NSF Funding to Biopharmaceuticals (Per $100,000 GSP, 2003)
3 4.01 91.71

SBIR Awards to Life Science (Per $100,000 GSP, 2003)
1 24.84 100.00

STTR Awards to Life Science (Per $100,000 GSP, 2003)
1 1.87 100.00

Biopharmaceutical Research Funding (Composite Index, 2004)
1 - 93.43

Biopharmaceutical Risk Capital Funding Rank Statistic Score

Total Venture Capital Investment to Biotech
(Relative Growth (US=100), Avg. 2001 - 2003)
11 125.40 64.86

Biotech Companies Receiving VC Investment
(Relative Growth (US=100), Avg. 2001 - 2003)
11 109.40 85.85

Biotech Venture Capital Investment (Per $100,000 GSP, Avg. 2001-2003)
1 181.23 100.00

Biopharmaceutical Risk Capital Funding (Composite Index, 2004)
1 - 90.14

Biopharmaceutical Human Capital & Workforce Rank Statistic Score

# of Graduate Students in Biopharmaceuticals
(Per 10,000 People (25 - 34 Age Cohort), 2001)
1 52.31 100.00

% of Bachelor's Degrees in Biopharmaceuticals
(Percent of Total Bachelor's Degrees, 2001)
15 5.79 88.97

# of Institutions Offering Biopharmaceuticals
(Per 100,000 People (25 - 34 Age Cohort), 2001)
15 5.89 68.10

Intensity of Biological Scientists (Per 100,000 Workers, 2003)
6 37.49 65.04

Intensity of Biochemists & Biophysicists (Per 100,000 Workers, 2003)
5 21.11 57.11

Intensity of Microbiologists (Per 100,000 Workers, 2003)
8 16.38 69.90

Intensity of Biological Technicians (Per 100,000 Workers, 2003)
11 73.09 74.90

Biopharmaceutical Human Cap & Workforce (Composite Index, 2004)
4 - 72.65

Biopharmaceutical Innovation Output Rank Statistic Score

FDA New Drugs Approval (Per 100,000 Employees, 2000-2003)
5 0.47 72.46

Clinical Trials (Phase I) (Per 100,000 Employees, Currently Recruiting)
3 3.23 76.03

Clinical Trials (Phase II) (Per 100,000 Employees, Currently Recruiting)
17 9.82 68.71

Clinical Trials (Phase III) (Per 100,000 Employees, Currently Recruiting)
35 7.85 59.72

Tech Fast 500 Companies in Biopharma (Per 100,000 Employees, 2003)
1 0.22 100.00

Biopharmaceutical Patents Issued (Per Patent, 1993-2003 Avg.)
2 7.12 98.27

Biopharmaceutical Patent Citations (Per Patent, 1993-2003 Avg.)
13 4.54 82.78

Percent of Patent in Biopharmaceuticals
(Percent of Total Patent, 1993-2003 Avg.)
2 11.57 91.43

Percent Growth in Biopharma Patenting (Percent, 1993-2003 Avg.)
28 15.33 61.81

Biopharmaceutical Current Impact Index (CII)
(Normalized Patent Citation, 1993-2003)
12 0.82 94.66

Biopharmaceutical Technological Strength
(Current Impact Index X # of Patents, Avg. 93-03)
2 366.30 90.98

Biopharmaceutical Technological Cycle Time (Avg. 1993-2003)
20 8.28 94.10

Biopharmaceutical Science Linkage (Average Citations, Avg. 1993-2003)
4 23.63 98.96

Biopharmaceutical Science Strength (Total Citations, Avg. 1993-2003)
2 5,752.18 91.28

Biopharmaceutical Innovation Output (Composite Index, 2004)
1 - 83.47

Innovation Pipeline Composite Index (2004) Rank Average Score

Biopharmaceutical Research Funding
1 93.43

Biopharmaceutical Risk Capital Funding
1 90.14

Biopharmaceutical Human Capital & Workforce
4 72.65

Biopharmaceutical Innovation Output
1 83.47

State Innovation Pipeline Index
1 85.83

Data Sources

Forecast Data 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Employment Level Forecast
Total Biopharmaceutical, In Thousands 22.68 23.69 24.94 26.28 27.71 29.16 30.70 32.23 33.79 35.47 37.26

Real Output Level Forecast
Total Biopharmcaeutical, In US$ '96 Millions 2,640.04 2,939.09 3,274.68 3,642.40 4,067.74 4,508.81 4,959.75 5,493.26 6,100.73 6,804.27 7,596.99

Earnings Level Forecast
Total Biopharmcaeutical, In US$ Millions 1,710.74 1,856.83 2,022.24 2,201.66 2,397.06 2,613.46 2,859.25 3,144.82 3,453.23 3,797.66 4,187.45

Employment Level Forecast
Pharmaceutical and Medicine Manufacturing (NAICS 3254), In Thousands 8.77 9.08 9.46 9.83 10.25 10.68 11.17 11.63 12.11 12.61 13.12

Real Output Level Forecast
Pharmaceutical and Medicine Manufacturing (NAICS-3254), In US$ '96 Millions 1,702.37 1,944.34 2,216.99 2,518.53 2,876.45 3,252.55 3,638.09 4,114.15 4,656.11 5,283.29 5,992.88

Earnings Level Forecast
Pharmaceutical and Medicine Manufacturing (NAICS-3254), In US$ Millions 893.566 979.348 1,075.324 1,189.396 1,315.901 1,454.898 1,612.558 1,790.431 1,996.852 2,221.296 2,472.293

Employment Level Forecast
R&D in the Life Sciences (NAICS-5417102), In Thousands 13.91 14.60 15.48 16.45 17.46 18.48 19.53 20.60 21.69 22.86 24.14

Real Output Level Forecast
R&D in the Life Sciences (NAICS-5417102), In US$ '96 Millions 937.67 994.75 1,057.69 1,123.88 1,191.30 1,256.26 1,321.66 1,379.11 1,444.62 1,520.98 1,604.11

Earnings Level Forecast
R&D in the Life Sciences (NAICS-5417102), In US$ Millions 731.40 781.50 832.84 885.76 942.17 1,000.90 1,068.82 1,147.97 1,231.94 1,325.37 1,427.37

Biopharmaceutical Employment Forecast

2004	2009	2014	Percent Growth
(Thous.)	(Thous.)	(Thous.)	(2004-2009)	(2009-2014)	(2004-2014)
22.68	29.16	37.26	29 %	28 %	64 %

Biopharmaceutical Real Output Forecast

2004	2009	2014	Percent Growth
(US$ 96, Mil.)	(US$ 96, Mil.)	(US$ 96, Mil.)	(2004-2009)	(2009-2014)	(2004-2014)
2,640.04	4,508.81	7,596.99	71%	68%	188%

Biopharmaceutical Earnings Forecast

2004	2009	2014	Percent Growth
(US$ Mil.)	(US$ Mil.)	(US$ Mil.)	(2004-2009)	(2009-2014)	(2004-2014)
1,710.74	2,613.46	4,187.45	53%	60%	145%

Biopharmaceutical Total Employment Forecast

2004	2009	2014	Percent Growth
(Thous.)	(Thous.)	(Thous.)	(2004-2009)	(2009-2014)	(2004-2014)
0.71%	0.87%	1.05%	21.2%	21.8%	47.6%

Biopharmaceutical Share of Total Real Output Forecast

2004	2009	2014	Percent Growth
(US$ Mil.)	(US$ Mil.)	(US$ Mil.)	(2004-2009)	(2009-2014)	(2004-2014)
0.94%	1.34%	1.95%	43.3%	44.7%	107.3%

Biopharmaceutical Share of Total Earnings Forecast

2004	2009	2014	Percent Growth
(US$ Mil.)	(US$ Mil.)	(US$ Mil.)	(2004-2009)	(2009-2014)	(2004-2014)
0.01	0.01	0.02	22%	33%	62%

Biopharmaceutical Employment Forecast — Multiplier Impacts, 2014

Direct-Effect Employment Multiplier	Total Impact (Thous.)	Direct Impact (Thous.)	Indirect + Induced (Thous.)	Induced Impact (Thous.)	Indirect Impact (Thous.)	Induced Share	Indirect Share
3.61	134.42	37.26	97.17	47.25	49.92	0.49	0.51

Biopharmaceutical Real Output Forecast — Multiplier Impacts, 2014

Final-Demand Output Multiplier	Total Impact (US$ 96, Mil.)	Direct Impact (US$ 96, Mil.)	Indirect + Induced (US$ 96, Mil.)	Induced Impact (US$ 96, Mil.)	Indirect Impact (US$ 96, Mil.)	Induced Share	Indirect Share
2.1	15,579.729	7,596.986	7,982.743	4,023.356	3,959.386	0.504	0.496

Biopharmaceutical Earnings Forecast — Multiplier Impacts, 2014

Direct-Effect Earnings Multiplier	Total Impact (US$ Mil.)	Direct Impact (US$ Mil.)	Indirect + Induced (US$ Mil.)	Induced Impact (US$ Mil.)	Indirect Impact (US$ Mil.)	Induced Share	Indirect Share
2.6	10,760.162	4,187.451	6,572.710	2,913.373	3,659.337	0.4	0.6

Biopharamceutical Research Funding	Rank	Statistic	Score

Industrial R&D to Biopharmaceutical (Dollars per Capita, 2002)	3	176.87	87.42
National Institutes of Health Funding (Total Dollars per Capita, 2003)	1	343.21	100.00
NIH Funding to Biopharmaceuticals (Dollars per Capita, 2003)	2	76.13	98.04
Academic R&D to Biopharmaceuticals (Dollars per Capita, 2002)	3	116.59	95.83
NSF Funding to Biopharmaceuticals (Per $100,000 GSP, 2003)	3	4.01	91.71
SBIR Awards to Life Science (Per $100,000 GSP, 2003)	1	24.84	100.00
STTR Awards to Life Science (Per $100,000 GSP, 2003)	1	1.87	100.00
Biopharmaceutical Research Funding (Composite Index, 2004)	1	-	93.43

Biopharmaceutical Risk Capital Funding	Rank	Statistic	Score

Total Venture Capital Investment to Biotech (Relative Growth (US=100), Avg. 2001 - 2003)	11	125.40	64.86
Biotech Companies Receiving VC Investment (Relative Growth (US=100), Avg. 2001 - 2003)	11	109.40	85.85
Biotech Venture Capital Investment (Per $100,000 GSP, Avg. 2001-2003)	1	181.23	100.00
Biopharmaceutical Risk Capital Funding (Composite Index, 2004)	1	-	90.14

Biopharmaceutical Innovation Output	Rank	Statistic	Score

FDA New Drugs Approval (Per 100,000 Employees, 2000-2003)	5	0.47	72.46
Clinical Trials (Phase I) (Per 100,000 Employees, Currently Recruiting)	3	3.23	76.03
Clinical Trials (Phase II) (Per 100,000 Employees, Currently Recruiting)	17	9.82	68.71
Clinical Trials (Phase III) (Per 100,000 Employees, Currently Recruiting)	35	7.85	59.72
Tech Fast 500 Companies in Biopharma (Per 100,000 Employees, 2003)	1	0.22	100.00
Biopharmaceutical Patents Issued (Per Patent, 1993-2003 Avg.)	2	7.12	98.27
Biopharmaceutical Patent Citations (Per Patent, 1993-2003 Avg.)	13	4.54	82.78
Percent of Patent in Biopharmaceuticals (Percent of Total Patent, 1993-2003 Avg.)	2	11.57	91.43
Percent Growth in Biopharma Patenting (Percent, 1993-2003 Avg.)	28	15.33	61.81
Biopharmaceutical Current Impact Index (CII) (Normalized Patent Citation, 1993-2003)	12	0.82	94.66
Biopharmaceutical Technological Strength (Current Impact Index X # of Patents, Avg. 93-03)	2	366.30	90.98
Biopharmaceutical Technological Cycle Time (Avg. 1993-2003)	20	8.28	94.10
Biopharmaceutical Science Linkage (Average Citations, Avg. 1993-2003)	4	23.63	98.96
Biopharmaceutical Science Strength (Total Citations, Avg. 1993-2003)	2	5,752.18	91.28
Biopharmaceutical Innovation Output (Composite Index, 2004)	1	-	83.47

Innovation Pipeline Composite Index (2004)	Rank	Average Score

Biopharmaceutical Research Funding	1	93.43
Biopharmaceutical Risk Capital Funding	1	90.14
Biopharmaceutical Human Capital & Workforce	4	72.65
Biopharmaceutical Innovation Output	1	83.47
State Innovation Pipeline Index	1	85.83

Forecast Data	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014
Employment Level Forecast Total Biopharmaceutical, In Thousands	22.68	23.69	24.94	26.28	27.71	29.16	30.70	32.23	33.79	35.47	37.26
Real Output Level Forecast Total Biopharmcaeutical, In US$ '96 Millions	2,640.04	2,939.09	3,274.68	3,642.40	4,067.74	4,508.81	4,959.75	5,493.26	6,100.73	6,804.27	7,596.99
Earnings Level Forecast Total Biopharmcaeutical, In US$ Millions	1,710.74	1,856.83	2,022.24	2,201.66	2,397.06	2,613.46	2,859.25	3,144.82	3,453.23	3,797.66	4,187.45
Employment Level Forecast Pharmaceutical and Medicine Manufacturing (NAICS 3254), In Thousands	8.77	9.08	9.46	9.83	10.25	10.68	11.17	11.63	12.11	12.61	13.12
Real Output Level Forecast Pharmaceutical and Medicine Manufacturing (NAICS-3254), In US$ '96 Millions	1,702.37	1,944.34	2,216.99	2,518.53	2,876.45	3,252.55	3,638.09	4,114.15	4,656.11	5,283.29	5,992.88
Earnings Level Forecast Pharmaceutical and Medicine Manufacturing (NAICS-3254), In US$ Millions	893.566	979.348	1,075.324	1,189.396	1,315.901	1,454.898	1,612.558	1,790.431	1,996.852	2,221.296	2,472.293
Employment Level Forecast R&D in the Life Sciences (NAICS-5417102), In Thousands	13.91	14.60	15.48	16.45	17.46	18.48	19.53	20.60	21.69	22.86	24.14
Real Output Level Forecast R&D in the Life Sciences (NAICS-5417102), In US$ '96 Millions	937.67	994.75	1,057.69	1,123.88	1,191.30	1,256.26	1,321.66	1,379.11	1,444.62	1,520.98	1,604.11
Earnings Level Forecast R&D in the Life Sciences (NAICS-5417102), In US$ Millions	731.40	781.50	832.84	885.76	942.17	1,000.90	1,068.82	1,147.97	1,231.94	1,325.37	1,427.37